Home » Topics » Regulatory

Regulatory
RSS

ML Laboratories granted second license from U.K. authorities for its dry powder inhaler

Nov. 17, 1998

Nolvadex now available for breast cancer prevention

Nov. 17, 1998

New oral ultrasound contrast agent approved by FDA

Nov. 17, 1998

Improved dosage form of selegiline now on the U.K. market

Nov. 11, 1998

ATTRACT study establishes efficacy, safety of infliximab in RA patients

Nov. 11, 1998

FDA approves Actiq for treatment of breakthrough cancer pain

Nov. 6, 1998

First Neoral equivalent cleared by FDA

Nov. 4, 1998

U.S. grants first approval for GelTex's novel phosphate-binding polymer therapeutic

Nov. 3, 1998

Genvir is as effective as Zovirax in genital herpes, with improved dosing

Nov. 3, 1998

Positive CPMP opinion issued for Betaseron in new indication

Nov. 2, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...